Skip to main content
. 2021 May 6;193(6):1203–1212. doi: 10.1111/bjh.17470

Fig 1.

Fig 1

Flow of the patients. A prospective, multicentre cross‐sectional study was conducted to test the hypothesis that a universal anti‐Xa assay would accurately measure rivaroxaban, apixaban, or edoxaban drug levels in clinical practice, and correctly predict clinically relevant drug levels.